March 20, 2023 – Page 5 – Goldea Capital

Snakes & Lattes Inc. Acquires a New Brick & Mortar Location in Virginia Beach, Virginia

Written by Customer Service on March 20, 2023. Posted in Mergers And Acquisitions.

TORONTO, ON, March 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Snakes & Lattes Inc. (OTC: FUNN) is pleased to announce the acquisition of ‘Roll With It’ Board Game Cafe & Bar (Roll With It) in Virginia Beach, Virginia via an all cash transaction. Acquisition Highlights: Completed acquisition of ‘Roll With It’ Board Game Café & Bar in Virginia Beach All cash deal Very popular, Operating Café & Bar with little competition in the area Strong revenue, well managed, with a similar company culture Over 4700 sq. ft. in a high-traffic area with lots of visibility and parking. Marks the first location on the East Coast of the USA (5th USA location To Date) Established in August 2021 by Quan Truong, ‘Roll With It’ is extremely well managed, has a great company culture, strong revenue and little to no competition...

Heidmar Inc. Announces Business Combination Agreement with Home Plate Acquisition Corporation

Written by Customer Service on March 20, 2023. Posted in Mergers And Acquisitions.

Heidmar Inc., a first-class commercial and pool management business servicing the crude oil and refined petroleum product tanker market announces plan to list on Nasdaq through merger with Home Plate Acquisition Corporation (NASDAQ GM: HPLT) Highlights Single platform aggregator of maritime services for tanker industry with unique asset light business model Strong cash position and no debt provides high flexibility for future growth Targeting minimum cash raise of $55 million, in a combination of expected PIPE raise and Trust cash Predictable fee-based earnings to further isolate Heidmar from freight rate exposure Targeted $0.30 per share dividend post-combination implies a sustainable yield of ~3% at a $10.00 per share price Pro forma equity value of the combined company would be approximately $261.4 million1 ATHENS, Greece, March...

Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update

Written by Customer Service on March 20, 2023. Posted in Earnings Releases And Operating Results.

Exploring a range of strategic alternatives Revenues from product sales from continued operations increased +27% Y/Y in 4Q 2022 and +33% for full year 2022 Net Loss attributable to Athenex was $34.2 million, or $4.28 per diluted share in 4Q2022, compared to $104.4 million, or $19.08 per diluted share, in the prior year quarter Cash, cash equivalents, and restricted cash balance of $35.6 million at year end Additional Phase 1 dose escalation study safety and preliminary efficacy data for KUR-502 CAR-NKT cell therapy product anticipated in 2H 2023 Phase 1 GINAKIT2 study of KUR-501 on clinical hold; pending serious adverse event investigation and safety risk mitigation planning to reopen clinical trial Graduation of Oral Paclitaxel combination regimen in the neoadjuvant triple-negative breast cancer treatment subgroup of I-SPY 2 trial BUFFALO,...

3D Systems Collaborates with TE Connectivity on Innovative Solution to Additively Manufacture Electrical Connectors

Written by Customer Service on March 20, 2023. Posted in Public Companies.

Novel workflow enables production of end-use parts in weeks versus months without tooling investment Unique photopolymer introduced with full UL recognition capable of meeting stringent connector application needs First known 3D photopolymer to complete long-term thermal aging for electrical and mechanical relative thermal index (RTI) certification. ROCK HILL, S.C., March 20, 2023 (GLOBE NEWSWIRE) — 3D Systems (NYSE:DDD) today announced its collaboration with TE Connectivity, a world leader in connectors and sensors, to jointly develop an additive manufacturing solution to produce electrical connectors meeting stringent UL regulatory requirements. The solution comprising 3D Systems’ Figure 4® Modular, Figure 4 material, 3D Sprint® software, and services was designed to meet TE Connectivity’s unique requirements for material performance...

PFSweb Announces Authorization of Share Repurchase Program

Written by Customer Service on March 20, 2023. Posted in Public Companies.

IRVING, Texas, March 20, 2023 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW) (the “Company”), a premier eCommerce order fulfillment provider, announced that its board of directors has authorized a share repurchase program, under which the Company may purchase up to an aggregate of 1,000,000 shares of its common stock. The program will be in place for up to two years. Subject to applicable rules and regulations, the shares may be purchased from time to time in the open market or in privately negotiated transactions. The share repurchase program will be conducted in accordance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. Such purchases will be at times and in amounts as PFSweb deems appropriate, based on factors such as market conditions, legal requirements, and business considerations. The share repurchase...

QSAM Biosciences to Provide Updates on its Clinical Trial at the Emerging Growth Conference on Wednesday, March 22, 2023

Written by Customer Service on March 20, 2023. Posted in Public Companies.

QSAM invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. Austin, TX, March 20, 2023 (GLOBE NEWSWIRE) — QSAM Biosciences, Inc. (OTCQB: QSAM), a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®), for the treatment of bone cancer and related diseases and conditions, is pleased to announce that it has been invited to provide updates on its clinical trial evaluating CycloSam® for the treatment of metastatic bone cancer at the Emerging Growth Conference on Wednesday, March 22, 2023, at 2:50 PM EST. The Emerging Growth Conference is a live, interactive online event that will give existing shareholders and the investment community the opportunity to interact with the...

US Nuclear Combats PFAS Contamination With Novel, On-the-Spot Detector

Written by Customer Service on March 20, 2023. Posted in Public Companies.

LOS ANGELES, CA, March 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — On Tuesday, March 14, 2023, the US Environmental Protection Agency (EPA) proposed a first-ever national standard establishing legally enforceable limits for six toxic PFAS forever chemicals. This was welcome news for US Nuclear Corp. (OTC-QB: UCLE) who recently developed and started selling the world’s first real-time PFAS monitor that can measure PFAS contamination in under a minute. Until now, there were only a few states that enforced PFAS regulations, and none as strict as what the EPA is now proposing. Public concern has grown substantially in recent years as new testing revealed the extent and danger of PFAS contamination to all Americans. If the proposal is finalized, businesses and drinking water providers across the country will need to start monitoring...

SuRo Capital Corp. Will Commence a Modified Dutch Auction Tender Offer to Repurchase up to 3 Million Shares of its Common Stock

Written by Customer Service on March 20, 2023. Posted in Public Companies.

NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) — SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) announced today that it will commence a modified “Dutch Auction” tender offer (the “Tender Offer”) to purchase up to 3 million shares of its common stock at a price per share not less than $3.00 and not greater than $4.50 in $0.10 increments, using available cash. “As we have consistently demonstrated, SuRo Capital is committed to initiatives that enhance shareholder value, and we believe the market is currently undervaluing our portfolio. Accordingly, on March 17, 2023, our Board of Directors authorized a modified Dutch Auction Tender Offer to purchase up to 3 million shares of our common stock at a price per share between $3.00 and $4.50. Given our stock is trading at a significant discount to net...

Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479

Written by Customer Service on March 20, 2023. Posted in Public Companies.

— IRAK4 Program Represents the First of Up to Five Degrader Programs Within the 2019 Discovery Collaboration Agreement — — Nurix to Receive a $20 Million Option Fee — FOSTER CITY, Calif. and SAN FRANCISCO, March 20, 2023 (GLOBE NEWSWIRE) — Gilead Sciences, Inc. (Nasdaq: GILD) and Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation therapies, today announced that Gilead has exercised its option to exclusively license Nurix’s investigational targeted protein degrader molecule NX-0479. This bivalent degrader, designated GS-6791, is the first development candidate resulting from the previously announced Nurix-Gilead collaboration to discover, develop, and commercialize a pipeline of innovative targeted protein degradation therapies. GS-6791...

Surgalign Launches Next Generation Software for its HOLO Portal™ Surgical Guidance System and Expands Surgical Tool Integration to Drive Use Case Adoption

Written by Customer Service on March 20, 2023. Posted in Public Companies.

The next iteration of HOLO Portal delivers advancements based on early clinical experience and insights from leading spine surgeons in the U.S. DEERFIELD, Ill., March 20, 2023 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced the first major upgrade of the HOLO Portal™ Surgical Guidance System since the first case was performed in May of 2022. Since launch, the Company has worked with surgeons to enhance system functionality and expand use cases in the operating room. This next generation system from Surgalign includes over 250 enhancements in software, hardware upgrades, and integration with new instrumentation, including over 20 new surgical tools designed for use with HOLO...

Day: March 20, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice